Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice
- PMID: 17469144
- DOI: 10.1002/art.22571
Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice
Abstract
Objective: To determine whether innate receptor signals play an important role in the development of autoimmune nephritis in MRL/lpr mice, an experimental model of lupus nephritis.
Methods: MyD88 is a critical adaptor that is involved in signaling pathways through all of the Toll-like receptors (TLRs) except TLR-3. We therefore generated MyD88-knockout (MyD88-KO) MRL/lpr mice and examined them for histopathologic changes in the kidneys, cumulative survival rates, extent of lymphadenopathy and splenomegaly, serum chemistry, and immunologic parameters. In addition, to define the role of the MyD88-independent pathway in autoimmune nephritis, we injected MyD88-KO MRL/lpr mice intraperitoneally with either poly(I-C) (50 or 100 microg per mouse) or phosphate buffered saline and examined them for survival as well as for histopathologic, serologic, and immunologic parameters.
Results: In comparison with wild-type mice, MyD88-KO MRL/lpr mice exhibited a prolonged lifespan, with no apparent development of autoimmune nephritis. Their kidneys showed no glomerular cell proliferation or crescent formation, along with a drastic decrease in the mesangial matrix. Lymphadenopathy and splenomegaly were less pronounced. Serum titers of anti-double-stranded DNA (anti-dsDNA) and production of cytokines, including interferon-alpha (IFNalpha), interleukin-12 (IL-12), IL-6, and IFNgamma, in splenocytes were significantly reduced in MyD88-KO MRL/lpr mice. Interestingly, MyD88-KO MRL/lpr mice that had been treated with the MyD88-independent TLR-3 ligand poly(I-C) showed an almost complete reversion to the features of wild-type mice, demonstrating crescentic glomerulonephritis, with significant elevation of serum anti-dsDNA titers and increased cytokine production in splenocytes.
Conclusion: The findings indicate that both MyD88-dependent and MyD88-independent innate signals play a crucial role in the development of autoimmune nephritis in MRL/lpr mice.
Similar articles
-
Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.Arthritis Rheum. 2005 Dec;52(12):3987-96. doi: 10.1002/art.21424. Arthritis Rheum. 2005. PMID: 16320345
-
Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.J Am Soc Nephrol. 2005 May;16(5):1326-38. doi: 10.1681/ASN.2004100820. Epub 2005 Mar 16. J Am Soc Nephrol. 2005. PMID: 15772251
-
Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.Arthritis Rheum. 2003 Feb;48(2):486-94. doi: 10.1002/art.10813. Arthritis Rheum. 2003. PMID: 12571859
-
Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci.Rev Immunogenet. 2000;2(1):154-64. Rev Immunogenet. 2000. PMID: 11324688 Review.
-
Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.Environ Health Perspect. 1998 Oct;106 Suppl 5(Suppl 5):1131-7. doi: 10.1289/ehp.98106s51131. Environ Health Perspect. 1998. PMID: 9788887 Free PMC article. Review.
Cited by
-
Mesenchymal stem cell transplantation can restore lupus disease-associated miRNA expression and Th1/Th2 ratios in a murine model of SLE.Sci Rep. 2016 Dec 7;6:38237. doi: 10.1038/srep38237. Sci Rep. 2016. PMID: 27924862 Free PMC article.
-
Association between Toll-Like Receptor 4 Polymorphisms and Systemic Lupus Erythematosus Susceptibility: A Meta-Analysis.Biomed Res Int. 2016;2016:7842587. doi: 10.1155/2016/7842587. Epub 2016 Aug 29. Biomed Res Int. 2016. PMID: 27652268 Free PMC article. Review.
-
Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.Clin Rev Allergy Immunol. 2017 Feb;52(1):133-147. doi: 10.1007/s12016-016-8549-4. Clin Rev Allergy Immunol. 2017. PMID: 27207173 Review.
-
Transforming Growth Factor-β and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals.Front Immunol. 2018 Jun 14;9:1364. doi: 10.3389/fimmu.2018.01364. eCollection 2018. Front Immunol. 2018. PMID: 29963056 Free PMC article.
-
The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.Front Immunol. 2024 May 10;15:1377913. doi: 10.3389/fimmu.2024.1377913. eCollection 2024. Front Immunol. 2024. PMID: 38799420 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials